SLP
ELV icon

Storen Legacy Partners’s Elevance Health ELV Stock Holding History

Storen Legacy Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Buy
+592
New +$220K 0.06% 100
2026
Q1 		– Sell
-592
Closed -$207K – 103
2025
Q4 		$207K Buy
+592
New +$200K 0.07% 74

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Storen Legacy Partners's ELV Position: Q2 2026 in Review

Storen Legacy Partners opened a new position in Elevance Health (ELV) in Q2 2026: 592 shares worth $229K. The stake represents 0.06% of the portfolio and ranks #100 among its holdings. This is a return to the name: Storen Legacy Partners previously reported a position in ELV as recently as Q4 2025.

Storen Legacy Partners first reported a position in ELV in Q4 2025 and has held it in 2 quarters since. 1,593 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Storen Legacy Partners held 592 shares of Elevance Health worth $229K as of Q2 2026.
  • Elevance Health was a new Storen Legacy Partners position in Q2 2026.
  • Elevance Health made up 0.06% of Storen Legacy Partners's portfolio in Q2 2026, its #100 holding.
  • Storen Legacy Partners first reported a position in Elevance Health in Q4 2025 and has held it in 2 quarters since.
  • 1,593 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Storen Legacy Partners's 13F filing for Q2 2026, filed 17 Jul 2026.